Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity KPTI - Karyopharm Therapeutics Inc.
164 M
LAST VALUE
-32.25%
2 YEAR CAGR
-11.03%
5 YEAR CAGR
-2.89%
10 YEAR CAGR